Aplastic anemia
Aplastic anemia (AA) is a disease in which the bone marrow hematopoietic stem cells and the bone marrow microenvironment are severely damaged by physical, chemical, biological or unknown factors, resulting in a decrease or failure of the bone marrow hematopoietic function. It is a group of syndromes with pancytopenia as the main manifestation. According to a survey in 21 provinces (cities) and autonomous regions in China, the annual incidence rate is 0.74/100,000 population, which is significantly lower than the incidence rate of leukemia; the incidence rate of chronic aplastic anemia is 0.60/100,000 population, and the incidence rate of acute aplastic anemia is 0.14/100,000 population; it can occur in all age groups, but it is more common in young and middle-aged people; the incidence rate in men is slightly higher than that in women.
-
Site of disease:
Bone marrow blood vessels
-
Infectious :
Not contagious
-
Frequent population:
Young adults, mostly males
-
Related symptoms:
Gastrointestinal bleeding
retinal bleeding and exudation
visceral bleeding
bleeding tendency
fatigue
Related Drugs
Recombinant human granulocyte-stimulating factor injection
Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.
Manufacturer:
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
Shengxue Pills
Manufacturer:
Darentang Pharmaceutical Factory of Tianjin Pharmaceutical Darentang Group Co., Ltd.
Aminopeptide
Indication: Used for idiopathic thrombocytopenic purpura, allergic purpura, leukopenia and aplastic anemia.
Manufacturer:
Zhejiang Guoguang Biopharmaceutical Co., Ltd.
Mannan peptide oral solution
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Manufacturer:
Jilin PROVINCE Tonghua Zhenguo Pharmaceutical Co., Ltd.
Mannan peptide oral solution
Indication: Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system.
Manufacturer:
Hainan Pharmaceutical FACTORY Co., Ltd.
Mannan peptide oral solution
Indication: Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the adverse reactions of radiotherapy and chemotherapy to the hematopoietic system and gastrointestinal reactions
Mannan peptide oral solution
Indication: Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the adverse reactions of radiotherapy and chemotherapy to the hematopoietic system and gastrointestinal reactions
Manufacturer:
China Resources Sanjiu (NanChang) Pharmaceutical Co., Ltd.
Mannan peptide oral solution
Indication: Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the adverse reactions of radiotherapy and chemotherapy to the hematopoietic system and gastrointestinal reactions
Mannan peptide oral solution
Indication: Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the adverse reactions of radiotherapy and chemotherapy to the hematopoietic system and gastrointestinal reactions
Manufacturer:
Jilin Wantong Pharmaceutical Group Meihe Pharmaceutical Co., Ltd.